Top Story

Imprimis reports $2.5 million net loss in third quarter

November 21, 2014

Imprimis Pharmaceuticals reported a net loss of $2.5 million, or $0.27 per common share, in the third quarter, compared with a loss of $2.1 million, or $0.23 per common share, in the third quarter of last year, according to a press release.

Total revenues were $0.4 million in the third quarter, an increase from $2,500 in total revenues the year before.

Meeting News Coverage

Pain-sensitive patients may report dry eye symptoms without pathology

November 21, 2014
DENVER – Pain sensitivity influences ocular discomfort and dryness perception, according to a speaker here at the American Academy of Optometry meeting.Wong Li…

Ocular Therapeutix to evaluate sustained-release travoprost for glaucoma, ocular hypertension

November 21, 2014
Ocular Therapeutix has begun enrolling the first subjects in a phase 2b clinical trial to evaluate the safety and efficacy of sustained-release travoprost, according to…
thumbnail for video 3902067011001 Meeting News CoverageVideo

Prevalence of diabetic retinopathy high among Puerto Ricans

November 20, 2014
Neisha Rodriguez, OD, MPH-G, reported in her poster at the American Academy of Optometry meeting that the majority of patients with diabetic retinopathy have the mild…

Valeant announces $2 billion Securities Repurchase Program

November 20, 2014
A new securities repurchase program that will allow Valeant Pharmaceuticals to make purchases up to $2 billion of its senior notes, common shares and other securities…
More News Headlines »
Postoperative Inflammation and Pain

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Meeting News Coverage Video
thumbnail for video 3900080232001

Surgeon gives pearls for dislocated IOLs

November 19, 2014
NEW YORK — At the OSN New York meeting here, Uday Devgan, MD, discusses pearls for properly diagnosing and…
More »